PHILADELPHIA, Oct. 14, 2025 /PRNewswire/ -- Integral Molecular, a leader in developing innovative tools for antiviral research, announces the launch of its Ready Reporter Virus™ (RRV) neutralization ...
Therefore, we administered a third 30-μg BNT162b2 dose 7.9 to 8.8 months after dose 2 to 11 participants 18 to 55 years of age and to 12 participants 65 to 85 years of age from U.S. sites in the phase ...
Beberapa hasil telah disembunyikan kerana ia mungkin tidak dapat dicapai oleh anda.
Tunjukkan hasil yang tidak boleh dicapai
